Delivery Order SPE2DB20D2014-SPE2DB25FA29S

Award Date 11/7/24
Potential Completion Date 11/8/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA29S
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,694.32 delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product.

The contract has an ultimate completion date of November 8, 2024 and is structured as a firm fixed price delivery order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the requested pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply programs.

Generated 2/6/25, 9:04 AM